Drug Discovery in the Synapse - Derek Small
Update: 2025-09-13
Description
In this episode of the Talking Biotech podcast, Dr. Kevin Folta interviews Derek Small, co-founder and CEO of Syndeoo, focusing on the increasing prevalence of neurological disorders and the challenges in developing effective therapies. They discuss the importance of synaptic function in mental health and neurodegenerative diseases, the innovative Boost platform for drug development, and the potential of event-driven pharmacology. The conversation highlights the hope for new treatments in the pipeline for conditions like depression and Alzheimer's disease.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
